$32.9 M

OVAS Mkt cap, 18-Jul-2018

$67 K

OvaScience Revenue Q1, 2018
OvaScience Gross profit (Q1, 2018)-45 K
OvaScience Gross profit margin (Q1, 2018), %(67.2%)
OvaScience Net income (Q1, 2018)-7.4 M
OvaScience EBIT (Q1, 2018)-7.6 M
OvaScience Cash, 31-Mar-201819.7 M

OvaScience Income Statement

Annual

USDFY, 2016

Revenue

653 k

R&D expense

21.6 m

General and administrative expense

49.2 m

Operating expense total

70.9 m

EBIT

(81 m)

EBIT margin, %

(12406%)

Interest expense

659 k

Interest income

659 k

Pre tax profit

(82.1 m)

Income tax expense

201 k

Net Income

(82.3 m)

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

Revenue

15 k30 k75 k146 k189 k197 k63 k67 k

Cost of goods sold

112 k

Gross profit

(45 k)

Gross profit Margin, %

(67%)

R&D expense

4.5 m5.3 m5.7 m4 m4 m6 m6 m5 m5.8 m2.6 m

General and administrative expense

5.1 m11 m13.1 m12.9 m14.5 m11.2 m12.6 m7.1 m4.2 m

Operating expense total

9.6 m5.3 m16.8 m17.1 m16.9 m20.4 m17.2 m17.6 m12.9 m7.6 m

EBIT

(9.6 m)(12.4 m)(16.8 m)(17.2 m)(17.8 m)(21.4 m)(18.2 m)(19 m)(14.6 m)(7.6 m)

EBIT margin, %

(112087%)(57247%)(23696%)(14684%)(9651%)(9626%)(23154%)(11316%)

Interest expense

101 k141 k

Interest income

101 k141 k191 k

Pre tax profit

(21.7 m)(18.5 m)(19.2 m)(14.9 m)(7.4 m)

Income tax expense

75 k50 k92 k9 k

Net Income

(9.9 m)(12.9 m)(17.2 m)(17.5 m)(17.9 m)(21.8 m)(18.6 m)(19.3 m)(14.9 m)(7.4 m)

OvaScience Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

18.1 m6.4 m43.2 m43.9 m

Inventories

650 k1.6 m3 m2.1 m

Current Assets

45.1 m61.9 m129.9 m116.4 m

PP&E

880 k3.4 m8.3 m5.6 m

Total Assets

47.5 m65.6 m138.6 m122.5 m

Accounts Payable

1.7 m2.5 m3.4 m2.2 m

Current Liabilities

5.8 m10.2 m11.2 m13.2 m

Total Liabilities

14.3 m

Additional Paid-in Capital

86.9 m150 m294.9 m358.4 m

Retained Earnings

(94.7 m)(167.9 m)(250.2 m)

Total Equity

41.7 m55.3 m126.9 m108.2 m

Financial Leverage

1.1 x1.2 x1.1 x1.1 x

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

Cash

16.6 m12.1 m134.7 m70.2 m50.8 m20.5 m95.9 m50.5 m25.4 m19.7 m

Current Assets

82.6 m73.6 m171.3 m159.2 m145.3 m112.7 m150.1 m133.5 m101.2 m59.1 m

PP&E

1.9 m3.1 m4.2 m4.2 m6.7 m8.7 m8.1 m8 m4.7 m2.9 m

Total Assets

85.8 m77.5 m175.8 m164.5 m152.8 m122.1 m158.7 m142.4 m106.3 m63 m

Accounts Payable

1.4 m3 m2.5 m3 m4.2 m4.2 m2.5 m2.8 m2.4 m1 m

Current Liabilities

7.1 m8.8 m6.6 m7.6 m9.9 m11.8 m10.7 m11.3 m10.6 m5 m

Total Liabilities

5.7 m

Additional Paid-in Capital

141.6 m144.4 m281 m286.2 m289.9 m298.5 m354.8 m357.4 m360.1 m366.2 m

Retained Earnings

(75.8 m)(111.9 m)(129.4 m)(147.3 m)(189.7 m)(208.2 m)(227.5 m)(265.4 m)(308.9 m)

Total Equity

78.7 m68.6 m169.1 m156.7 m142.6 m108.8 m146.6 m129.9 m94.7 m57.3 m

Financial Leverage

1.1 x1.1 x1 x1 x1.1 x1.1 x1.1 x1.1 x1.1 x1.1 x

OvaScience Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(2.6 m)(49.5 m)(73.2 m)(82.3 m)

Depreciation and Amortization

450 k1.3 m2.2 m

Accounts Payable

276 k2.3 m(171 k)(1.2 m)

Cash From Operating Activities

(1.6 m)(30.6 m)(50.3 m)(61.7 m)

Purchases of PP&E

(2.8 m)(5.2 m)(2.6 m)

Cash From Investing Activities

(32.8 m)(38.3 m)8.3 m

Cash From Financing Activities

6.1 m51.7 m125.4 m54.1 m

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

Net Income

(9.9 m)(12.9 m)(17.2 m)(17.5 m)(17.9 m)(21.8 m)(18.6 m)(19.3 m)(14.9 m)(7.4 m)

Depreciation and Amortization

330 k

Accounts Payable

1.4 m3 m2.5 m3 m4.2 m4.2 m2.5 m2.8 m2.4 m(1.4 m)

Cash From Operating Activities

(8.9 m)

Cash From Investing Activities

13 m

OvaScience Ratios

USDY, 2018

Financial Leverage

1.1 x
Report incorrect company information